Ozempic
- Product NDC
- 0169-4772
- 11-digit product format
- 001694772
- Labeler code
- 0169
- Product ID
- 0169-4772_852fff2d-704e-4b01-9244-439a28094202
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2022-04-25
- Substance
- SEMAGLUTIDE
- Active strength
- 2.68 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209637-001 | OZEMPIC | SEMAGLUTIDE | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | |
| N209637-002 | OZEMPIC | SEMAGLUTIDE | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | |
| N209637-003 | OZEMPIC | SEMAGLUTIDE | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | |
| N209637-004 | OZEMPIC | SEMAGLUTIDE | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | |
| N209637-005 | OZEMPIC | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-006 | OZEMPIC | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-007 | OZEMPIC | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | |
| N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | |
| N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | |
| N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | |
| N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | |
| N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-003 | 12295988 | 2038-10-10 | U-2628 | 2025-05-29 | |
| N209637-004 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8536122 | 2026-03-20 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8129343 | 2031-12-05 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10335462 | 2033-06-21 | U-2580 | Drug product | 2022-11-14 |
| N209637-004 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-004 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-005 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-005 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-005 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 12214017 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-4561 | Drug product | 2026-06-23 |
| N209637-006 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-006 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-006 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-006 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N209637-001 | I-961 | 2028-01-28 |
| N209637-002 | I-961 | 2028-01-28 |
| N209637-003 | I-961 | 2028-01-28 |
| N209637-004 | I-961 | 2028-01-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-005 | OZEMPIC | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-006 | OZEMPIC | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-007 | OZEMPIC | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | d8e5a09893c0… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-004 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | D-185 | 2025-03-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | D-185 | 2025-03-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | D-185 | 2025-03-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | D-185 | 2025-03-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | D-185 | 2025-03-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | D-185 | 2025-03-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | D-185 | 2025-03-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-003 | D-185 | 2025-03-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-003 | D-185 | 2025-03-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209637-003 | D-185 | 2025-03-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209637-003 | D-185 | 2025-03-28 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209637-003 | D-185 | 2025-03-28 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N209637-003 | D-185 | 2025-03-28 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | D-185 | 2025-03-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 5d02ea3f76ae… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ozempic
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SEMAGLUTIDE | 2.68 mg/mL |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9dd2abc7-744f-456b-a273-dec083824bd8 | Product name | 2 | 20240229 |
| 487bac84-7c5b-40cf-afd2-8b9674d4648e | Product name | 1 | 20220118 |
| 21318a8d-e167-4f44-9627-3daede9532ff | Product name | 1 | 20200227 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0169-4772-11 | Ozempic | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-4772-12 | Ozempic | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 19 | |
| 0169-4772-90 | Ozempic | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-4772-97 | Ozempic | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 19 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-4772-11 | ML - Milliliter | 0169-4772 | c976c79b-9525-4307-a8be-93d75859ecdf | 1 | 2022-04-06 |
| 0169-4772-12 | ML - Milliliter | 0169-4772 | bc3a577b-f6f9-455b-b119-a3fd1758e7b5 | 1 | 2022-04-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 42bdd912-2393-44c4-b7e0-47672ca28991 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 979e4df4-0597-48ea-b51c-0f699fa6d166 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| OZEMPIC | SEMAGLUTIDE | A-S Medication Solutions | e6da837c-0da0-41d6-973c-5559bf764367 | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1991311 | OZEMPIC 2 MG in 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991317 | OZEMPIC 2 MG in 1.5 ML Pen Injector, 1 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619154 | OZEMPIC 2 MG in 3 ML Pen Injector, 0.25 or 0.5 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398842 | OZEMPIC 4 MG in 3 ML Pen Injector | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991306 | semaglutide 2 MG in 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991316 | semaglutide 2 MG in 1.5 ML Pen Injector, 1 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619152 | semaglutide 2 MG in 3 ML Pen Injector, 0.25 MG, 0.5 MG Dose | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398841 | semaglutide 4 MG in 3 ML Pen Injector | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599362 | semaglutide 8 MG in 3 ML Pen Injector | PSN | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991311 | 0.25 MG, 0.5 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] | SBD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619154 | 0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector [Ozempic] | SBD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991317 | 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] | SBD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398842 | 3 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] | SBD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599365 | 3 ML semaglutide 2.68 MG/ML Pen Injector [Ozempic] | SBD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991306 | 0.25 MG, 0.5 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector | SCD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619152 | 0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector | SCD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991316 | 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector | SCD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398841 | 3 ML semaglutide 1.34 MG/ML Pen Injector | SCD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599362 | 3 ML semaglutide 2.68 MG/ML Pen Injector | SCD | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991311 | 0.25 MG, 0.5 MG Dose 1.5 ML Ozempic 1.34 MG/ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619154 | 0.25 MG, 0.5 MG Dose 3 ML Ozempic 0.68 MG/ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2619152 | 0.25 MG, 0.5 MG Dose semaglutide 2 MG per 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991317 | 1 MG Dose 1.5 ML Ozempic 1.34 MG/ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398842 | 3 ML Ozempic 1.34 MG/ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991311 | OZEMPIC 2 MG per 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991317 | OZEMPIC 2 MG per 1.5 ML Pen Injector, 1 MG Dose | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599365 | Ozempic 2.68 MG/ML per 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599365 | Ozempic 8 MG per 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991306 | semaglutide 2 MG per 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 1991316 | semaglutide 2 MG per 1.5 ML Pen Injector, 1 MG Dose | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599362 | semaglutide 2.68 MG/ML per 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2398841 | semaglutide 4 MG in 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599362 | semaglutide 8 MG per 3 ML Pen Injector | SY | adec4fd2-6858-4c99-91d4-531f5f2a2d79 | 19 |
| 2599365 | OZEMPIC 8 MG in 3 ML Pen Injector | PSN | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599362 | semaglutide 8 MG in 3 ML Pen Injector | PSN | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599365 | 3 ML semaglutide 2.68 MG/ML Pen Injector [Ozempic] | SBD | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599362 | 3 ML semaglutide 2.68 MG/ML Pen Injector | SCD | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599365 | Ozempic 2.68 MG/ML per 3 ML Pen Injector | SY | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599365 | Ozempic 8 MG per 3 ML Pen Injector | SY | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599362 | semaglutide 2.68 MG/ML per 3 ML Pen Injector | SY | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
| 2599362 | semaglutide 8 MG per 3 ML Pen Injector | SY | e6da837c-0da0-41d6-973c-5559bf764367 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0169-4772-11 | 00169477211 | 3 mL in 1 SYRINGE, PLASTIC | 3 ml | Historical | ||||
| 0169-4772-12 | 00169477212 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-12) / 3 mL in 1 SYRINGE, PLASTIC (0169-4772-11) | 2022-04-25 | 0000-00-00 | No | No | Current | |
| 0169-4772-90 | 00169477290 | 3 mL in 1 SYRINGE, PLASTIC | 3 ml | Historical | ||||
| 0169-4772-97 | 00169477297 | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4772-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-4772-90) | 2022-04-25 | 0000-00-00 | Yes | No | Current |